Julia M L Brotherton
- Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination programSuzanne M Garland
Regional World Health Organisation Human Papillomavirus Laboratory Network, Department of Microbiology and Infectious Diseases, The Royal Women s Hospital, Locked Bag 300, Parkville, Victoria 3052, Australia
BMC Med 9:104. 2011..Prior to introduction of a national human papilloma virus (HPV) vaccination program, we determined HPV genotype prevalence by Indigenous status and residence in remote areas...
- Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, AustraliaJulia M L Brotherton
Victorian Cytology Service, East Melbourne 8002, Victoria, Australia
Cancer Epidemiol 36:298-302. 2012..To assess human papillomavirus (HPV) vaccination coverage and attitudes to vaccination and Pap screening in young women...
- Does HPV type 16 or 18 prevalence in cervical intraepithelial neoplasia grade 3 lesions vary by age? An important issue for postvaccination surveillanceJulia M L Brotherton
Regional WHO Human Papillomavirus Laboratory Network, Department of Microbiology and Infectious Diseases, The Royal Women s Hospital, Locked Bag 300, Parkville, Victoria 3052, Australia
Future Microbiol 7:193-9. 2012....
- Mobile phones are a viable option for surveying young Australian women: a comparison of two telephone survey methodsBette Liu
The Kirby Institute, University of New South Wales, Sydney, Australia
BMC Med Res Methodol 11:159. 2011..We therefore sought to examine the feasibility of recruiting young women for a national health survey through random digit dialling mobile phones...
- National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination ProgramJulia M L Brotherton
Victorian Cytology Service, East Melbourne, Australia
Sex Health 7:291-8. 2010..We investigated GPs' experiences of delivering the HPV vaccine to women aged 18-26...
- Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategyJulia M L Brotherton
Victorian Cytology Service, East Melbourne, Australia
Sex Health 7:310-9. 2010..Australia is well placed to monitor the impact of its HPV vaccination program as well as to measure vaccine effectiveness with existing HPV vaccines, cervical screening and cancer registries...
- Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological studyJulia M L Brotherton
Victorian Cytology Service Registries, Victorian Cytology Service, East Melbourne, Vic, Australia
Lancet 377:2085-92. 2011..We analysed trends in cervical abnormalities in women in Victoria, Australia, before and after introduction of the vaccination programme...
- The incidence of genital warts in Australian women prior to the national vaccination programJulia M L Brotherton
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children s Hospital at Westmead and the University of Sydney, Westmead, NSW 2145, Australia
Sex Health 6:178-84. 2009..A surveillance system capable of documenting any decrease in the incidence of genital warts and recurrent respiratory papillomatosis after vaccination is urgently required...
- Interim estimates of human papillomavirus vaccination coverage in the school-based program in AustraliaJulia M L Brotherton
National Centre for Immunisation Research and Surveillance and University of Sydney, New South Wales
Commun Dis Intell Q Rep 32:457-61. 2008..Public sector immunisation providers across Australia should be commended for planning and implementing a new national immunisation program in approximately 4 months...
- Primary prophylactic human papillomavirus vaccination programs: future perspective on global impactJulia M L Brotherton
National HPV Vaccination Program Register, Victorian Cytology Service Registries, Victorian Cytology Service, PO Box 310, East Melbourne, Victoria 8002, Australia
Expert Rev Anti Infect Ther 9:627-39. 2011..This article considers the current issues and challenges in delivering primary HPV vaccination programs effectively and the likely impact of the vaccines in both the near and more distant future...
- Catching up with the catch-up: HPV vaccination coverage data for Australian women aged 18-26 years from the National HPV Vaccination Program RegisterJulia Brotherton
National HPV Vaccination Program Register, East Melbourne, Victoria
Commun Dis Intell Q Rep 35:197-201. 2011..Some of the differences in the coverage observed between states and territories likely reflect differing mechanisms for notifying to the Register...
- Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and preventionSuzanne M Garland
Department of Microbiology and Infectious Diseases, The Royal Women s Hospital, Melbourne, Victoria, Australia
Vaccine 26:M80-8. 2008..This represents a successful model for other countries. We present data on cervical cancer, risk factors and prevention strategies, including epidemiology of HPV and HPV vaccine strategies...
- Fall in human papillomavirus prevalence following a national vaccination programSepehr N Tabrizi
Regional World Health Organization Human Papillomavirus Laboratory Network, Department of Microbiology and Infectious Diseases, The Royal Women s Hospital, Victoria, Australia
J Infect Dis 206:1645-51. 2012..We evaluated the program's impact on genotype-specific HPV infection prevalence through a repeat survey of women attending clinical services...
- "I just signed": Factors influencing decision-making for school-based HPV vaccination of adolescent girlsSpring Chenoa Cooper Robbins
Discipline of Paediatrics and Child Health, University of Sydney, Australia, at The Children s Hospital at Westmead, Sydney, Australia
Health Psychol 29:618-25. 2010..To date, there are no published studies describing decision-making processes and behavior postimplementation of HPV vaccination of adolescents participating in a school-based program...
- Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, AustraliaDorota M Gertig
Victorian Cytology Service, PO Box 161, Carlton South, VIC 3053, Australia
Sex Health 8:171-8. 2011..Future monitoring of vaccine effectiveness will be facilitated by cross-linking to Pap test registries...
- Adolescent and young adult HPV vaccination in Australia: achievements and challengesSuzanne M Garland
Department of Microbiology and Infectious Diseases, The Royal Women s Hospital, Parkville, Victoria, Australia
Prev Med 53:S29-35. 2011..Challenges for the future include how we can sustain and improve HPV vaccination coverage in young Australian women, while maintaining cervical cancer screening participation and reviewing cervical cancer screening methods...
- How much cervical cancer in Australia is vaccine preventable? A meta-analysisJulia M L Brotherton
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children s Hospital at Westmead and the University of Sydney, Locked Bag 4001, NSW 2145, Australia
Vaccine 26:250-6. 2008..7% of cervical cancers. This finding implies that Australia may have more to gain from the adoption of currently formulated HPV vaccines than other countries...
- The predicted impact of vaccination on human papillomavirus infections in AustraliaMegan A Smith
Cancer Epidemiology Research Unit, The Cancer Council New South Wales, Woolloomooloo, New South Wales, Australia
Int J Cancer 123:1854-63. 2008..In conclusion, the current vaccination program is expected to result in a substantial and rapid reduction in the incidence of HPV16 in Australia...
- Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in AustraliaAnthony T Newall
School of Public Health, University of Sydney, New South Wales, Australia
Clin Infect Dis 46:1647-55. 2008..Seroepidemiology is a valuable tool, although the relationship between HPV infection and seropositivity is incomplete...
- Probability of coincident vaccination in the 24 or 48 hours preceding sudden infant death syndrome death in AustraliaJulia M L Brotherton
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Children s Hospital at Westmead, University of Sydney, Sydney, New South Wales, Australia
Pediatrics 115:e643-6. 2005..This study aimed to determine the probability that an Australian infant who has died of SIDS was vaccinated in the days before death...